| One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease |
| |
| 引用本文： | ZHANG Qi ZHANG Rui-yan ZHANG Jian-sheng HU Jian YANG Zhen-kun NI Jun FANG Yue-hua ZHANG Xian SHEN Wei-feng. One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease[J]. 中华医学杂志(英文版), 2006, 119(2): 165-168 |
| |
| 作者姓名： | ZHANG Qi ZHANG Rui-yan ZHANG Jian-sheng HU Jian YANG Zhen-kun NI Jun FANG Yue-hua ZHANG Xian SHEN Wei-feng |
| |
| 作者单位： | Department of Cardiology, Ruijin Hospital, Shanghai Jiaotong University, Shanghai 200025, China |
| |
| 摘 要： | The application of drug-eluting stent （DES）, either sirolimus-eluting stent （Cypher, Cordis, USA） or paclitaxel-eluting stent （Taxus, Boston Scientific, USA）, in treatment of patients with coronary artery disease （CAD） has achieved great success. The high cost of imported DES （either Cypher or Taxus） gave the birth to a China-made, polymer-based, sirolimus-eluting stent （Firebird, Microport Company,
|
| 关 键 词： | 冠状动脉疾病 血管狭窄 治疗 病理机制 |
| 收稿时间： | 2005-07-20 |
One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease |
| |
| ZHANG;Qi;ZHANG;Rui-yan;ZHANG;Jian-sheng;HU;Jian;YANG;Zhen-kun;NI;Jun;FANG;Yue-hua;ZHANG;Xian;SHEN;Wei-feng. One-year clinical outcomes of Chinese sirolimus-eluting stent in the treatment of unselected patients with coronary artery disease[J]. Chinese medical journal, 2006, 119(2): 165-168 |
| |
| Authors: | ZHANG Qi ZHANG Rui-yan ZHANG Jian-sheng HU Jian YANG Zhen-kun NI Jun FANG Yue-hua ZHANG Xian SHEN Wei-feng |
| |
| Abstract: | |
| |
| Keywords: | coronary artery disease stent restenosis sirolimus |
| 本文献已被 CNKI 维普 等数据库收录！ |
| 点击此处可从《中华医学杂志(英文版)》浏览原始摘要信息 |
|
点击此处可从《中华医学杂志(英文版)》下载全文 |
